INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 349 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $218 | -18.7% | 9,760 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $268 | -10.1% | 9,760 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $298 | -98.7% | 9,760 | -98.5% | 0.00% | -98.3% |
Q3 2023 | $23,030 | +5686.4% | 648,879 | +6548.4% | 0.06% | +2850.0% |
Q2 2023 | $398 | +9.3% | 9,760 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $364 | +6.7% | 9,760 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $341 | -99.9% | 9,760 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $546,000 | +8.1% | 9,760 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $505,000 | -28.8% | 9,760 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $709,000 | -38.7% | 9,760 | -0.2% | 0.00% | -40.0% |
Q4 2021 | $1,156,000 | -11.9% | 9,779 | 0.0% | 0.01% | -16.7% |
Q3 2021 | $1,312,000 | -17.1% | 9,779 | 0.0% | 0.01% | -14.3% |
Q2 2021 | $1,583,000 | +101.7% | 9,779 | 0.0% | 0.01% | +75.0% |
Q1 2021 | $785,000 | +47.6% | 9,779 | 0.0% | 0.00% | +33.3% |
Q4 2020 | $532,000 | – | 9,779 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |